Rachel Vaknin - Feb 22, 2024 Form 4 Insider Report for Microbot Medical Inc. (MBOT)

Role: Chief Financial Officer
Signature: /s/ Rachel Vaknin
Stock symbol: MBOT
Transactions as of: Feb 22, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/26/2024, 06:41 PM
Previous filing: Aug 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MBOT	Stock Option (Right to Buy)	Award	$0	+17.5K		$0.00	17.5K	Feb 22, 2024	Common Stock, par value $0.01 per share	17.5K	$1.27	Direct	F1
transaction	MBOT	Stock Option (Right to Buy)	Award	$0	+17.5K		$0.00	17.5K	Feb 22, 2024	Common Stock, par value $0.01 per share	17.5K	$1.27	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

Content

The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.